<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-12-31</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-12-31</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>51</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ç ”ç©¶æ­ç¤ºäº†ç»†èŒè¡ç”Ÿçš„å²å“š-3-ä¹³é…¸åœ¨è‚ é“ç‚ç—‡ä¸­è°ƒæ§ä¸Šçš®-å·¨å™¬ç»†èƒä¸²æ‰°çš„å…³é”®ä½œç”¨ï¼›é¦–æ¬¡åˆ©ç”¨å•æ ¸ç”²åŸºåŒ–æµ‹åºè§£æäº†å¤§è„‘è¡°è€çš„è¡¨è§‚é—ä¼ å­¦ç‰¹å¾ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   <strong>å…ç–«ä¸ç‚ç—‡è°ƒæ§</strong>ï¼šç ”ç©¶ç»†èŒä»£è°¢ç‰©å¯¹è‚ é“ç‚ç—‡çš„å½±å“ï¼Œæ¢ç©¶PIEZO1è°ƒæ§å·¨å™¬ç»†èƒæåŒ–åœ¨å¿ƒè„ç‚ç—‡ä¸­çš„ä½œç”¨ï¼Œåˆ†æè‚¿ç˜¤å¾®ç¯å¢ƒä¸­å·¨å™¬ç»†èƒçš„ä½œç”¨ï¼Œä»¥åŠåŒ–ç–—è¯±å¯¼çš„Kupfferç»†èƒåˆ†åŒ–åœ¨è‚è½¬ç§»ä¸­çš„æœºåˆ¶ã€‚<br />
*   <strong>ç¥ç»ç§‘å­¦ä¸ç–¾ç—…</strong>ï¼šè§£æè„‘è¡°è€çš„è¡¨è§‚é—ä¼ å­¦æœºåˆ¶ï¼Œç ”ç©¶ç¯å¢ƒæ¯’ç´ å¯¹ç¥ç»å…ƒæŸ“è‰²è´¨å¯åŠæ€§å’Œè½¬å½•ç»„çš„å½±å“ï¼Œä»¥åŠFn14åœ¨ç¥ç»å…ƒæ´»åŠ¨å’Œæ˜¼å¤œèŠ‚å¾‹ä¸­çš„ä½œç”¨ã€‚<br />
*   <strong>è‚¿ç˜¤å‘ç”Ÿä¸æ²»ç–—</strong>ï¼šæ¢ç´¢M2å‹è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒåœ¨èƒ¶è´¨ç˜¤è¿›å±•ä¸­çš„ä½œç”¨ï¼Œç ”ç©¶2pæ‰©å¢é©±åŠ¨çš„RELè¿‡è¡¨è¾¾å¯¹æ…¢æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…BTKæŠ‘åˆ¶å‰‚è€è¯æ€§çš„å½±å“ï¼Œä»¥åŠRASä¿¡å·æŠ‘åˆ¶å‰‚å¯¹KRASG12Cçªå˜éå°ç»†èƒè‚ºç™Œå…ç–«æ²»ç–—çš„å¢æ•ä½œç”¨ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   <strong>å¤šç»„å­¦æ•´åˆåˆ†æ</strong>ï¼šç»“åˆRNA-Seqã€ATAC-Seqã€Hi-Cã€å•æ ¸ç”²åŸºåŒ–æµ‹åºç­‰æŠ€æœ¯ï¼Œå¤šç»´åº¦è§£æåŸºå› è°ƒæ§å’Œç»†èƒçŠ¶æ€ã€‚<br />
*   <strong>å•ç»†èƒä¸ç©ºé—´åˆ†è¾¨ç‡æŠ€æœ¯</strong>ï¼šåº”ç”¨scRNA-seqå’ŒHi-CæŠ€æœ¯ï¼Œæ·±å…¥ç†è§£ç»†èƒå¼‚è´¨æ€§åŠä¸‰ç»´åŸºå› ç»„ç»“æ„ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ä¸¤é¡¹ç ”ç©¶åœ¨å¦Šå¨ æœŸç³–å°¿ç—…å¯¹åä»£å½±å“åŠè¡°è€å…ç–«ç³»ç»Ÿé‡å¡‘æ–¹é¢å–å¾—æ–°è¿›å±•ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- å¦Šå¨ æœŸç³–å°¿ç—…é€šè¿‡æ‰°ä¹±èƒç›˜RNAå‰ªæ¥ï¼Œå½±å“åä»£ä»£è°¢åŸºå› è°ƒæ§ã€‚<br />
- é¶å‘é€’é€mRNAè‡³è‚è„ï¼Œå¯æš‚æ—¶é‡å¡‘è¡°è€å…ç–«ç³»ç»ŸåŠŸèƒ½ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- åˆ©ç”¨RNAæµ‹åºæŠ€æœ¯æ­ç¤ºå¦Šå¨ æœŸç³–å°¿ç—…å¯¹èƒç›˜RNAå‰ªæ¥çš„å½±å“ã€‚<br />
- é€šè¿‡mRNAé€’é€ç­–ç•¥æ¿€æ´»å…ç–«ä¿¡å·é€šè·¯ï¼Œå®ç°å…ç–«ç³»ç»ŸåŠŸèƒ½æ¢å¤ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (49æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE228937 ç»†èŒæ¥æºçš„å²å“š-3-ä¹³é…¸é€šè¿‡è°ƒèŠ‚ä¿¡å·ä¼ å¯¼å’Œä»£è°¢é€”å¾„å½±å“è‚ é“ç‚ç—‡æœŸé—´ä¸Šçš®-å·¨å™¬ç»†èƒçš„ç›¸äº’ä½œç”¨ [EC]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šbacteriaã€macrophageã€inflammationã€regex:bacter(ia|ial|ium)ã€metabolicã€regex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Kaiyuan Yu ; Qianqian Li ; Xuan SunSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensTo investigate the the effect of EC-TMU supernatant on on intestinal epithelial cells, SW480 cells were stimulated with EC-TMU supernatant.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228937" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE228409 ç»†èŒæ¥æºçš„å²å“š-3-ä¹³é…¸é€šè¿‡è°ƒèŠ‚ä¿¡å·ä¼ å¯¼å’Œä»£è°¢é€”å¾„å½±å“è‚ é“ç‚ç—‡æœŸé—´ä¸Šçš®ç»†èƒ-å·¨å™¬ç»†èƒçš„ç›¸äº’ä½œç”¨</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šbacteriaã€macrophageã€inflammationã€regex:bacter(ia|ial|ium)ã€metabolicã€regex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Yu KaiyuanSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensTo investigate the underlying molecular mechanism of ILA effect on CCL2/7 expression, we examined the gene expression profiles of SW480 cells treated by LPS and ILA using RNA sequencing<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228409" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE181141 é€šè¿‡å•æ ¸ç”²åŸºåŒ–æµ‹åºç ”ç©¶å¤§è„‘è¡°è€çš„è¡¨è§‚é—ä¼ ç‰¹å¾ [FC-9mo-m]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šagingã€sequencingã€epigeneticã€methylation<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Wei Tian ; Anna Bartlett ; Jordan Altshul ; Rosa Gomez Castanon ; Joseph R Nery ; Jacinta D Lucero ; Julia K Osteen ; Huaming Chen ; M M Behrens ; Joseph R EckerSeries Type : Methylation profiling by high throughput sequencingOrganism : Mus musculusIllustrating aging effects on the epigenomic features of brain is critical to understand brain functional decline and neurodegeneration. Single nucleus methylation sequencing was applied to brain regions of both male and female mouse at the age of 2, 9 and 18 months. We use these data to identify the epigenomic changes with aging in mouse brains.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE181141" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE311976 Piezo1æ•²ä½æ¿€æ´»PI3K/AKTå¹¶å¢å¼ºSPP1ä»¥é©±åŠ¨M2å·¨å™¬ç»†èƒæåŒ–å¹¶å‡å°‘å¿ƒè„ç‚ç—‡</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmacrophageã€inflammationã€cardiac<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yunhan Zhang ; Ying Zhang ; Jiaoyan Song ; Ziwen Zhao ; Wenhao Ju ; Hao Zhang ; Shuang LiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusWe have successfully established a mouse model with myeloid cell-specific knockdown of Piezo1. The intraperitoneal injection of lipopolysaccharide (LPS) resulted in a significant increase in cardiac macrophage infiltration, as well as an increase in the expression of inflammatory factors and the inflammatory response. However, myeloid cell-specific knockdown of Piezo1 impaired this response, leading to an increase in macrophage polarization towards the M2 type and the decreased inflammatory response. As a result, myocardial injury caused by sepsis was attenuated. We have also demonstrated that the PI3K/AKT pathway is significantly activated after Piezo1 knockdown, resulting in reduced myocardial dysfunction.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311976" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE249704 é‡ç”Ÿå‹ä¸APOE-KOå°é¼ è‚¿ç˜¤å¼•æµæ·‹å·´ç»“é©»ç•™CD11c+ç»†èƒçš„è½¬å½•è°±</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€lymphã€regex:lymph(o|atic)?<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Benjamin N OstendorfSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusHere, we analyze transcriptional profiles of CD11c+ enriched cells from the lymph nodes draining E0771-cOC tumors in either wildtype or APOE-KO mice.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249704" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE315177 M2å‹è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒè¡ç”Ÿçš„CCL-18ä¿ƒè¿›èƒ¶è´¨ç˜¤ç»†èƒå¢æ®–ï¼Œä½†ä¸ä»‹å¯¼èƒ¶è´¨ç˜¤æ”¾å°„æŠ—æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€macrophageã€glioma<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Xiuping ZhouSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensMost of glioma patients still experience relapse after radiotherapy owing to the formation of tumor immunosuppressive microenvironment. However, the comprehensive landscape of immune cell infiltration and the molecular mechanisms mediating glioma recurrence within the tumor microenvironment remains unclear. Bulk RNA-seq analysis revealed the significant changes in the immune system including increased total tumor-associated macrophages (TAMs) and elevated immune-suppressive M2 type TAMs in recurrent gliomas accepting radiotherapy. Meanwhile, C-C motif chemokine 18 (CCL-18) was the highest elevated molecule after radiotherapy. Consistently, the above results were confirmed in tissue microarray containing 23 pairs gliomas. Notably, low-dose fractionated radiation promoted TAM polarization into M2-TAMs accompanying CCL-18 secretion in vitro. Unexpectedly, CCL-18 promoted non-irradiated glioma cell proliferation, but did not mediate glioma radioresistance both in vivo and in vitro. Our findings indicate that the tumor microenvironment of recurrent gliomas accepting radiotherapy changes obviously, which exhibited the elevation of total TAM infiltration, M2-TAM polarization and CCL-18 expression. Remarkably, elevated CCL-18 promotes glioma cell proliferation, but does not mediate glioma radioresistance.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315177" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE315113 å¸•é‡‘æ£®ç—…ç¯å¢ƒæ¯’ç´ æš´éœ²çš„äººç±»ç¥ç»å…ƒæ¨¡å‹ä¸­çš„æŸ“è‰²è´¨å¯åŠæ€§å’Œè½¬å½•ç»„ [ATAC-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šNeuronalã€ATAC-seqã€transcriptome<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jingchao Hong ; Juanjuan HuangSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensParkinson's disease is a complex neurodegenerative disorder where environmental factors play a predominant role in sporadic cases. While environmental toxins are implicated in PD pathogenesis via epigenetic pathways, the specific alterations in chromatin accessibility induced by these toxins remain poorly characterized. To address this gap, we established in vitro models using the human neuroblastoma cell line SH SY5Y, a well established neuronal model, exposed to the PD associated environmental toxins rotenone and MPP+. We performed RNA sequencing to profile the transcriptome and Assay for Transposase-Accessible Chromatin sequencing to map genome-wide chromatin accessibility landscapes under toxin exposed conditions. This integrated dataset provides a comprehensive resource detailing both gene expression and chromatin accessibility dynamics in response to PD relevant environmental neurotoxins and will facilitate investigations into transcriptional regulation, biomarker discovery, and the epigenetic basis of environmentally linked sporadic PD.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315113" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>GSE315111 å¸•é‡‘æ£®ç—…ç¯å¢ƒæ¯’ç´ æš´éœ²çš„äººç±»ç¥ç»å…ƒæ¨¡å‹ä¸­çš„æŸ“è‰²è´¨å¯åŠæ€§å’Œè½¬å½•ç»„ [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šNeuronalã€RNA-seqã€transcriptome<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jingchao Hong ; Juanjuan HuangSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensParkinson's disease is a complex neurodegenerative disorder where environmental factors play a predominant role in sporadic cases. While environmental toxins are implicated in PD pathogenesis via epigenetic pathways, the specific alterations in chromatin accessibility induced by these toxins remain poorly characterized. To address this gap, we established in vitro models using the human neuroblastoma cell line SH SY5Y, a well established neuronal model, exposed to the PD associated environmental toxins rotenone and MPP+. We performed RNA sequencing to profile the transcriptome and Assay for Transposase-Accessible Chromatin sequencing to map genome-wide chromatin accessibility landscapes under toxin exposed conditions. This integrated dataset provides a comprehensive resource detailing both gene expression and chromatin accessibility dynamics in response to PD relevant environmental neurotoxins and will facilitate investigations into transcriptional regulation, biomarker discovery, and the epigenetic basis of environmentally linked sporadic PD.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315111" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE285990 åŒ–ç–—é€šè¿‡ä¿ƒè¿›è‚è½¬ç§»ä¸­ LEPR+ Kupffer ç»†èƒåˆ†åŒ–æ¥è§¦å‘å…ç–«é€ƒé€¸ [RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jun Qin ; Xuege Wang ; Qiang Pan ; Yaqi LiSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Homo sapiens ; Mus musculusConventional chemotherapy achieves clinical efficacy beyond its cytotoxic effects by reactivating immune surveillance. However, whether chemotherapy promotes immune evasion by remodeling the tumor microenvironment (TME) remains largely unexplored. Here, we integrate cross-species single-cell and spatial transcriptomics to explore how chemotherapy reprograms immune cell dynamics and plasticity. Our findings reveal a central role for chemotherapy-educated, liver-resident Kupffer cells (KCs) in promoting immune tolerance and chemoresistance in liver metastases. These reprogrammed KCs, characterized by leptin receptor expression (LEPR+), originate from preexisting KCs and are differentiated via STING-ID1 signaling triggered by cGAMP released from chemotherapy-treated tumor cells. Unlike conventional KCs, LEPR+ KCs infiltrate tumors and engage in MerTK-dependent efferocytosis, which diminishes chemotherapy-induced immunogenic cell death (ICD) and suppresses antitumor immunity. Notably, targeting LEPR+ KCs enhances tumor immunogenicity and strengthens antitumor T-cell responses. Our study demonstrates that therapy-induced KC differentiation fosters immune evasion and suggests combining efferocytosis inhibitors with immunotherapy to overcome chemoresistance.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285990" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE285989 åŒ–ç–—é€šè¿‡ä¿ƒè¿›è‚è½¬ç§»ä¸­ LEPR+ Kupffer ç»†èƒåˆ†åŒ–æ¥è§¦å‘å…ç–«é€ƒé€¸ [CUT&amp;Tag, ATAC-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€ATAC-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jun Qin ; Xuege Wang ; Qiang Pan ; Yaqi LiSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusConventional chemotherapy achieves clinical efficacy beyond its cytotoxic effects by reactivating immune surveillance. However, whether chemotherapy promotes immune evasion by remodeling the tumor microenvironment (TME) remains largely unexplored. Here, we integrate cross-species single-cell and spatial transcriptomics to explore how chemotherapy reprograms immune cell dynamics and plasticity. Our findings reveal a central role for chemotherapy-educated, liver-resident Kupffer cells (KCs) in promoting immune tolerance and chemoresistance in liver metastases. These reprogrammed KCs, characterized by leptin receptor expression (LEPR+), originate from preexisting KCs and are differentiated via STING-ID1 signaling triggered by cGAMP released from chemotherapy-treated tumor cells. Unlike conventional KCs, LEPR+ KCs infiltrate tumors and engage in MerTK-dependent efferocytosis, which diminishes chemotherapy-induced immunogenic cell death (ICD) and suppresses antitumor immunity. Notably, targeting LEPR+ KCs enhances tumor immunogenicity and strengthens antitumor T-cell responses. Our study demonstrates that therapy-induced KC differentiation fosters immune evasion and suggests combining efferocytosis inhibitors with immunotherapy to overcome chemoresistance.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285989" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 39 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (2æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>RNAæµ‹åºæ­ç¤ºäº†å¦Šå¨ æœŸç³–å°¿ç—…å¦‚ä½•å½±å“åä»£çš„æ–°çº¿ç´¢</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šRNA sequencing reveals that gestational diabetes disrupts placental RNA splicing, altering metabolic gene regulation and implicating SRSF10 as a key molecular driver of pregnancy-related complications...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/rna-seq-reveals-new-clues-how-gestational-diabetes-affects-offspring/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>éº»çœç†å·¥å­¦é™¢çš„ç§‘å­¦å®¶ä»¬æ‰¾åˆ°äº†ä¸€ç§æ–¹æ³•ï¼Œå¯ä»¥å¸®åŠ©æˆ‘ä»¬éšç€å¹´é¾„çš„å¢é•¿æ¢å¤å…ç–«ç³»ç»Ÿçš„æ´»åŠ›ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmune<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šAs the immune system weakens with age, scientists have found a way to restore some of its lost strength. By delivering mRNA to the liver, they created a temporary source of immune-boosting signals that normally come from the thymus. Older mice treated this way produced more effective T cells and responded far better to vaccines and cancer treatments. The strategy could one day help extend healthy years of life.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/12/251227082718.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>RNA-seq</td>
<td>7</td>
</tr>
<tr>
<td>Neuronal</td>
<td>7</td>
</tr>
<tr>
<td>cancer</td>
<td>6</td>
</tr>
<tr>
<td>ATAC-seq</td>
<td>5</td>
</tr>
<tr>
<td>immune</td>
<td>5</td>
</tr>
<tr>
<td>macrophage</td>
<td>4</td>
</tr>
<tr>
<td>transcriptome</td>
<td>4</td>
</tr>
<tr>
<td>genome</td>
<td>4</td>
</tr>
<tr>
<td>inflammation</td>
<td>3</td>
</tr>
<tr>
<td>tumor</td>
<td>3</td>
</tr>
<tr>
<td>histone</td>
<td>3</td>
</tr>
<tr>
<td>methylation</td>
<td>3</td>
</tr>
<tr>
<td>scRNA</td>
<td>3</td>
</tr>
<tr>
<td>regex:intestin(e</td>
<td>al)</td>
</tr>
<tr>
<td>leukemia</td>
<td>2</td>
</tr>
<tr>
<td>T cell</td>
<td>2</td>
</tr>
<tr>
<td>immunity</td>
<td>2</td>
</tr>
<tr>
<td>kinase</td>
<td>2</td>
</tr>
<tr>
<td>sequencing</td>
<td>2</td>
</tr>
<tr>
<td>transcriptomics</td>
<td>2</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (39æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310954" target="_blank" rel="noopener noreferrer">GSE310954 é€šè¿‡é¢—ç²’ä»‹å¯¼çš„ STING/IL-6/PD-L1 è½´è°ƒèŠ‚é‡å¡‘æŠ‘åˆ¶æ€§é»‘è‰²ç´ ç˜¤å¾®ç¯å¢ƒå¯æ”¹å–„è‚¿ç˜¤å…ç–«å’Œå­˜æ´»ç‡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292026" target="_blank" rel="noopener noreferrer">GSE292026 2på¢ç›Šé©±åŠ¨çš„RELè¿‡è¡¨è¾¾èµ‹äºˆæ…¢æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…å¯¹BTKæŠ‘åˆ¶å‰‚çš„è€è¯æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315010" target="_blank" rel="noopener noreferrer">GSE315010 RAS(ON)æŠ‘åˆ¶å‰‚åŒè¯é˜»æ–­è‡´ç™ŒRASä¿¡å·é€šè·¯ï¼Œä½¿å…ç–«éš¾æ²»æ€§KRASG12Cçªå˜å‹éå°ç»†èƒè‚ºç™Œå¯¹å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­ç–—æ³•äº§ç”Ÿå…ç–«ååº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288563" target="_blank" rel="noopener noreferrer">GSE288563 é”Œç¼ºä¹æœŸé—´ KAT7 ä¾èµ–æ€§ç»„è›‹ç™½ H3K14 ä¹™é…°åŒ–å—æŸçš„ç—…ç†ç”Ÿç†æ„ä¹‰ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277238" target="_blank" rel="noopener noreferrer">GSE277238 ICAM1 mRNAé€šè¿‡dsRNA-ILF2/ILF3é€šè·¯æŠ‘åˆ¶è‚ºç™Œä¸­çš„ç¿»è¯‘ï¼Œå…¶åŠŸèƒ½ç‹¬ç«‹äºè›‹ç™½è´¨ç¼–ç ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315059" target="_blank" rel="noopener noreferrer">GSE315059 ç»†èƒå› å­å—ä½“Fn14æ˜¯ç¥ç»å…ƒæ´»åŠ¨çš„åˆ†å­åˆ¹è½¦ï¼Œä»‹å¯¼ä½“å†…æ˜¼å¤œèŠ‚å¾‹åŠŸèƒ½ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315057" target="_blank" rel="noopener noreferrer">GSE315057 å•ç»†èƒè½¬å½•ç»„å­¦æ­ç¤ºä¹³è…ºç™Œè‚‰ç˜¤çš„ç»„ç»‡ç»“æ„</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315048" target="_blank" rel="noopener noreferrer">GSE315048 RNAæµ‹åºï¼š16Då‰åˆ—è…ºç™Œç»†èƒç³»ä¸­OGDHLåŸºå› æ•²é™¤å’Œæ¢å¤çš„RNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315014" target="_blank" rel="noopener noreferrer">GSE315014 DOT1Lä»‹å¯¼çš„CDK9ç”²åŸºåŒ–å¯¹DNAåŒé“¾æ–­è£‚ä¿®å¤è‡³å…³é‡è¦[RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300387" target="_blank" rel="noopener noreferrer">GSE300387 é¼»å†…æ··åˆç–—æ³•ï¼ˆå«åŸºäºdNS1çš„ç—…æ¯’å’ŒSTFKBç–«è‹—ï¼‰å¯è¯±å¯¼å…¨èº«å’Œé»è†œä½“æ¶²å…ç–«ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299617" target="_blank" rel="noopener noreferrer">GSE299617 ä½“å¤–å…¨èƒ½ç»†èƒæ¨¡å‹çš„ 3D åŸºå› ç»„æ™¯è§‚åˆ†æ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299616" target="_blank" rel="noopener noreferrer">GSE299616 ä½“å¤–å…¨èƒ½ç»†èƒæ¨¡å‹çš„ 3D åŸºå› ç»„æ™¯è§‚ [Hi-C]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299615" target="_blank" rel="noopener noreferrer">GSE299615 ä½“å¤–å…¨èƒ½ç»†èƒæ¨¡å‹çš„ 3D åŸºå› ç»„æ™¯è§‚åˆ†æ [ATAC-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291085" target="_blank" rel="noopener noreferrer">GSE291085 æ¿€é…¶æŠ‘åˆ¶å‰‚å¤„ç†çš„ç™Œç»†èƒç³»è½¬å½•ç»„åˆ†ææ­ç¤ºäº†è¯ç‰©ååº”æœºåˆ¶çš„è§è§£</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286357" target="_blank" rel="noopener noreferrer">GSE286357 äººç±»ç¥ç»å‘ç”Ÿå’Œç¥ç»å…ƒæˆç†Ÿè¿‡ç¨‹ä¸­æ—¶é—´åŠ¨æ€çš„è½¬å½•è°ƒæ§ [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285570" target="_blank" rel="noopener noreferrer">GSE285570 äººç±»ç¥ç»å‘ç”Ÿå’Œç¥ç»å…ƒæˆç†Ÿè¿‡ç¨‹ä¸­æ—¶é—´åŠ¨æ€çš„è½¬å½•è°ƒæ§ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285531" target="_blank" rel="noopener noreferrer">GSE285531 äººç±»ç¥ç»å‘ç”Ÿå’Œç¥ç»å…ƒæˆç†Ÿè¿‡ç¨‹ä¸­æ—¶é—´åŠ¨æ€çš„è½¬å½•è°ƒæ§ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE218861" target="_blank" rel="noopener noreferrer">GSE218861 æƒ°æ€§åŸå‘æ€§çš®è‚¤Bç»†èƒæ·‹å·´ç˜¤ç±»ä¼¼äºæŒç»­æ€§æŠ—åŸååº”ï¼Œä½†æ— å»åˆ†åŒ–è¿¹è±¡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312951" target="_blank" rel="noopener noreferrer">GSE312951 æ€¥æ€§é«“ç³»ç™½è¡€ç—…ä¿ƒè¿›3å‹å›ºæœ‰æ·‹å·´ç»†èƒçš„å‘è‚²å’ŒåŠŸèƒ½</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303423" target="_blank" rel="noopener noreferrer">GSE303423 LXRæ¿€åŠ¨å‰‚åœ¨åˆå§‹CD8+ Tç»†èƒä¸­å¼•å‘æ•ˆåº”å‰çŠ¶æ€[ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249709" target="_blank" rel="noopener noreferrer">GSE249709 LXRæ¿€åŠ¨å‰‚å¢å¼ºäº¤å‰å‘ˆé€’åçš„Tç»†èƒæ´»åŒ–ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249707" target="_blank" rel="noopener noreferrer">GSE249707 LXRæ¿€åŠ¨å‰‚ä¿ƒè¿›æ ‘çªçŠ¶ç»†èƒäº¤å‰å¯åŠ¨åTç»†èƒæ•ˆåº”æŸ“è‰²è´¨æ™¯è§‚çš„å½¢æˆã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315139" target="_blank" rel="noopener noreferrer">GSE315139 å°èƒ¶è´¨ç»†èƒ CLEC7A æŠ‘åˆ¶é˜¿å°”èŒ¨æµ·é»˜ç—…å°é¼ æ¨¡å‹ä¸­çš„Î²-æ·€ç²‰æ ·è›‹ç™½æ–‘å—ç—…ç†</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307132" target="_blank" rel="noopener noreferrer">GSE307132 Doxè¯±å¯¼çš„Cas13è¡¨è¾¾åœ¨ç¨³å®šç»†èƒç³»ä¸­å¯¹å°é¼ è½¬å½•ç»„å’Œå…±åŸ¹å…»çš„äººç±»PSCçš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288565" target="_blank" rel="noopener noreferrer">GSE288565 é”Œç¼ºä¹æœŸé—´ KAT7 ä¾èµ–æ€§ç»„è›‹ç™½ H3K14 ä¹™é…°åŒ–å—æŸçš„ç—…ç†ç”Ÿç†æ„ä¹‰ [ChIP-seq_Hela]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288564" target="_blank" rel="noopener noreferrer">GSE288564 é”Œç¼ºä¹æœŸé—´ KAT7 ä¾èµ–æ€§ç»„è›‹ç™½ H3K14 ä¹™é…°åŒ–å—æŸçš„ç—…ç†ç”Ÿç†æ„ä¹‰ [ChIP-seq_å°é¼ ]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280372" target="_blank" rel="noopener noreferrer">GSE280372 ETC-501 æ˜¯ä¸€ç§å¯ç©¿é€è¡€è„‘å±éšœçš„ MNK æ¿€é…¶æŠ‘åˆ¶å‰‚ï¼Œå®ƒèƒ½å¢å¼ºæ›¿è«å”‘èƒº (TMZ) è¯±å¯¼çš„ç»†èƒè¡°è€ï¼Œå¹¶ä½¿èƒ¶è´¨æ¯ç»†èƒç˜¤ç»†èƒå¯¹è¡°è€ç»†èƒæ¸…é™¤ç–—æ³•æ›´åŠ æ•æ„Ÿã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315038" target="_blank" rel="noopener noreferrer">GSE315038 çœŸæ ¸ç¿»è¯‘èµ·å§‹å› å­3Bé€šè¿‡ä¸RAB14ç›¸äº’ä½œç”¨è°ƒæ§èƒ°è…ºç™Œç»†èƒå¢æ®–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313238" target="_blank" rel="noopener noreferrer">GSE313238 åˆ©ç”¨è„Šç´¢ç»†èƒå†ç”Ÿæ½œèƒ½çš„ç”Ÿç‰©æ´»æ€§æ°´å‡èƒ¶å¯ä½œä¸ºé«“æ ¸ä¿®å¤çš„æŒ‡å¯¼æ€§ç»†èƒè½½ä½“ [scRNA-seq dog]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313236" target="_blank" rel="noopener noreferrer">GSE313236 ä¸€ç§åˆ©ç”¨è„Šç´¢ç»†èƒå†ç”Ÿæ½œèƒ½çš„ç”Ÿç‰©æ´»æ€§æ°´å‡èƒ¶å¯ä½œä¸ºé«“æ ¸ä¿®å¤çš„æŒ‡å¯¼æ€§ç»†èƒè½½ä½“ [scRNA-seq human]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303905" target="_blank" rel="noopener noreferrer">GSE303905 KNSTRNåŸºå› æ•²ä½ä¼šæŸå®³è‡ªå™¬é€šé‡ï¼Œå¹¶é€šè¿‡ROSä»‹å¯¼çš„æº¶é…¶ä½“åŠŸèƒ½éšœç¢æŠ‘åˆ¶è†€èƒ±ç™Œçš„è¿›å±•ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303320" target="_blank" rel="noopener noreferrer">GSE303320æŸ“è‰²è´¨å¯åŠæ€§åŠ¨æ€å˜åŒ–æç¤ºç»´ç”Ÿç´ D3åœ¨ä½“å†…å…·æœ‰å…ç–«è°ƒèŠ‚ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299942" target="_blank" rel="noopener noreferrer">GSE299942 CBX7ï¼Œä¸€ç§å¤šæ¢³æŠ‘åˆ¶å› å­ï¼Œåœ¨æ·‹å·´ç»†èƒä¸­å‘æŒ¥ç”²åŸºåŒ–ä¾èµ–æ€§è½¬å½•æ¿€æ´»å› å­å’Œèƒè´¨ä¿¡å·è°ƒèŠ‚å› å­çš„ä½œç”¨ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299619" target="_blank" rel="noopener noreferrer">GSE299619 ä½“å¤–å…¨èƒ½ç»†èƒæ¨¡å‹çš„ 3D åŸºå› ç»„æ™¯è§‚åˆ†æ [CUT&amp;Tag]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299582" target="_blank" rel="noopener noreferrer">GSE299582ï¼šä¸æ°åŠ æ–¯ç—…æ˜“æ„Ÿæ€§å’Œæ…¢æ€§æ°åŠ æ–¯å¿ƒè‚Œç—…ä¸¥é‡ç¨‹åº¦ç›¸å…³çš„å¾ªç¯microRNAè½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289089" target="_blank" rel="noopener noreferrer">GSE289089 ç¡çœ å‰¥å¤ºå°é¼ å°è‚ éšçªç»†èƒäºšç¾¤åŠåŸºå› è¡¨è¾¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285532" target="_blank" rel="noopener noreferrer">GSE285532 äººç±»ç¥ç»å‘ç”Ÿå’Œç¥ç»å…ƒæˆç†Ÿè¿‡ç¨‹ä¸­æ—¶é—´åŠ¨æ€çš„è½¬å½•è°ƒæ§ [CUT&amp;Tag]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE263483" target="_blank" rel="noopener noreferrer">GSE263483 åŸºäºèƒç›˜è½¬å½•ç»„å­¦çš„å¦Šå¨ æœŸç³–å°¿ç—…å®«å†…é«˜è¡€ç³–å¯¹å­ä»£å‘è‚²çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE189685" target="_blank" rel="noopener noreferrer">GSE189685 å¤–æ³Œä½“Nm23-H1æ°´å¹³å‡é«˜é€šè¿‡æ”¹å˜ä¸‹æ¸¸ä¿¡å·çº§è”æŠ‘åˆ¶ä¹³è…ºç™Œç»†èƒæ¥æºå¤–æ³Œä½“çš„ä¿ƒè¿ç§»æ½œèƒ½</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-30 21:38</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>